February 26, 2013 - Blood Cancer Treatment - Making Informed Choices
Your order contains item(s) View Order
- Understanding goals of treatment for your diagnosis
- Understanding your treatment options
- Benefits and risks for standard treatments and investigational treatments
- Key facts about clinical trials
Stephen D. Nimer, MD
Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Questions Asked by the Blood Cancer Community
- I was diagnosed with cytopenia (a reduction in the number of cells circulating in the blood). Do you recommend getting a bone marrow aspiration or biopsy? What about a second opinion?
- With a diagnosis of relapsed chronic lymphocytic leukemia, is a stem cell transplant the next treatment step?
- Why do some patients relapse and become resistant to treatment?
- If lenalidomide (Revlimid®) is not working, can a patient switch to pomalidomide (Pomalyst®)?
- Is being a bone marrow donor dangerous?
- At what point does treatment start for a patient diagnosed with chronic lymphocytic leukemia?
- Is whole genome sequencing done routinely? How can a patient get a personalized approach to treatment?